Core Scientific, Inc. CORZ Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$798.36M+40.5% | -$1.11B-19.2% | -$1.07B-2,928% | ||
| $65.83M-36.7% | $68.91M-39.1% | $80.86M-31.7% | $93.22M-18.2% | $103.94M-0.9% | ||
| $99.81M+44.3% | $98.24M+89.2% | $94.27M+107% | $84.85M+113% | $69.17M+51.8% | ||
| -$23.31M-5,787% | -$9.68M-130% | -$7.25M-31.8% | -$4.83M+9.4% | -$396K+93.1% | ||
| $30.95M+284% | $10.78M+188% | -$18.25M-124% | -$17.17M-120% | -$16.83M-118% | ||
| -$36.47M-344% | -$17.4M-1,026% | $71.69M-1.1% | $38.35M-57.7% | $14.94M-87.6% | ||
| —— | —— | —— | —— | —— | ||
| $11.76M+33.3% | $11.27M+62.9% | $11.36M— | $9.57M— | $8.82M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$606K-104% | $24.87M-2.5% | ||
| $573.17M+2,457% | $278.25M+549% | $138.99M+174% | $12.92M-74.4% | -$24.32M-136% | ||
| $1.03B+603% | $729M+668% | $482.95M+520% | $269.63M+446% | $147.05M+216% | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| —— | —— | —— | —— | —— | ||
| $6.09M— | $3.46M— | $1.93M— | $1.67M— | —— | ||
| —— | —— | —— | —— | $5M— | ||
| -$1.04B-582% | -$740.75M-678% | -$496.22M— | -$273.1M— | -$152.24M— | ||
| $995M— | $0— | -$20M— | —— | —— | ||
| —— | —— | —— | $285.08M+370% | $295.07M+450% | ||
| $2.26M-24.6% | $1.67M-72.3% | $2.38M-57.3% | $2.7M-54.0% | $2.99M-58.5% | ||
| —— | —— | —— | —— | —— | ||
| $912.48M+17.6% | -$63.1M-108% | $556.88M+155% | $744.43M+3,499% | $776.2M+7,131% | ||
| $447.26M-25.7% | -$525.6M-167% | $199.64M-3.6% | $484.24M— | $601.62M— | ||
| —— | —— | —— | —— | —— | ||
| -$27.47M-124% | -$31.6M-1,881% | $29.26M+3,804% | $18.1M+3,199% | -$12.28M— | ||
| —— | —— | -$4.4M+94.5% | -$9.58M+86.9% | -$27.51M+34.1% | ||
| —— | —— | —— | -$606K-104% | $24.87M-2.5% | ||
| $54.49M— | $22.79M— | $29.04M— | —— | —— | ||
| $11.76M+33.3% | $11.27M+62.9% | $11.36M— | $9.57M— | $8.82M— | ||
| $208.25M-16.6% | $0-100% | $71.56M-83.4% | $139.49M-70.0% | $249.65M-45.3% | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| $192.39M-43.9% | $229.71M-46.0% | $283.81M-34.1% | $294.32M-36.6% | $342.74M-24.7% | ||
| —— | —— | —— | —— | $5M— | ||
| —— | —— | —— | —— | —— | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| $6.09M— | $3.46M— | $1.93M— | $1.67M— | —— | ||
| $2.26M-24.6% | $1.67M-72.3% | $2.38M-57.3% | $2.7M-54.0% | $2.99M-58.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $6.73M+30.6% | $6.91M+41.5% | $4.72M+147% | $5.15M+1,303% | $5.15M— | ||
| —— | —— | —— | —— | —— | ||
| -$461.08M-169% | -$450.75M-766% | -$343.97M-1,171% | -$256.71M-23,459% | -$171.37M-923% | ||
| -$461.08M-169% | -$450.75M-766% | -$343.97M-1,171% | -$256.71M-23,459% | -$171.37M-923% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Core Scientific, Inc. generate?
- Core Scientific, Inc. (CORZ) generated $573.2M in operating cash flow over the trailing twelve months.
- What is Core Scientific, Inc.'s free cash flow?
- After $1.0B of capital expenditures, Core Scientific, Inc.'s free cash flow was -$461.1M over the trailing twelve months, down 169.1% year over year.
- Where does Core Scientific, Inc.'s cash flow data come from?
- Every line is extracted from Core Scientific, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
